
Real data from 1,000+ VC rounds raised in the lat 6 months. Let's dig in:
𝗦𝗲𝗲𝗱 𝗦𝘁𝗮𝗴𝗲
Valuations are hitting new records, with median now at $25M for AI startups
Cash raised continues to rise as well
Dilution has fallen a bit from the 20% level down to 18% median.
𝗦𝗲𝗿𝗶𝗲𝘀 𝗔
$90M median for AI...that's pricey.
Much larger money raised for AI than not during this round
𝗦𝗲𝗿𝗶𝗲𝘀 𝗕
Widening gap in valuation for AI here
Startups are selling 12%-13% of the company on median
𝗦𝗲𝗿𝗶𝗲𝘀 𝗖
Continuation of the same pattern where AI startups are preferred strongly to non-AI
9% dilution
𝗦𝗲𝗿𝗶𝗲𝘀 𝗗
Valuations in the billions, round sizes between $50M-$100M
Note this data is for software startups only. Excludes biotech, hardware, medical devices, etc.
Some notes for founders, per usual:
Your round is not a "median" round. These benchmarks should be used to develop a shared sense of reality, not as specific targets.
The highest valuation is not always the best choice 😁
Amount of money raised and valuation are two major variables of a multivariate equation. Perhaps optimizing for terms, board seats, control, or other provisions matters more to you than the big dollar signs.
Comparison remains the thief of joy.
Good luck raising!
DISCLOSURE: This communication is on behalf of eShares, Inc. dba Carta, Inc. ("Carta"). This communication is for informational purposes only, and contains general information only. Carta is not, by means of this communication, rendering accounting, business, financial, investment, legal, tax, or other professional advice or services. This publication is not a substitute for such professional advice or services nor should it be used as a basis for any decision or action that may affect your business or interests. Before making any decision or taking any action that may affect your business or interests, you should consult a qualified professional advisor. This communication is not intended as a recommendation, offer or solicitation for the purchase or sale of any security. Carta does not assume any liability for reliance on the information provided herein. © 2026 Carta. All rights reserved. Reproduction prohibited.



